Baha Bone Conduction Implants and Magnetic Resonance Imaging
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Bone Anchored Devices
- Sponsor
- Fondation Ophtalmologique Adolphe de Rothschild
- Enrollment
- 20
- Locations
- 1
- Primary Endpoint
- Artifact size, measured in millimeters, on MRI sequences.
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
Bone conduction implants (BCI) are widely used in cases of conductive/ mixed hearing loss or single side deafness when surgical treatment or air hearing aids are not feasible. There are two types of BCI, abutments (which pass through the skin) and magnets (where a subcutaneous magnet is coupled to an external magnet). Pathologies (such as cholesteatoma) leading to the insertion of this hearing implant often require prolonged MRI follow-up. However, both the abutment and the magnet are responsible for imaging artifacts that limit its interpretation. Frequency and extent of these artifacts remain unclear in the literature. In our experience, the magnet, due to its size and composition, produces larger artifacts than the abutment. The main objective of our study is to compare MRI artifacts for each of these device types (abutment and magnet).
Detailed Description
The patients included in the study will all have a cerebral MRI as part of the cholesteatoma follow-up or for the assessment of cerebral or inner ear pathology. * ENT evaluation: The position of the implant will be evaluated. The distance from the external ear canal (center of the abutment or center of the magnet) will be measured on the patient using a ribbon meter. The angle between the implant and the orbital plane (in degrees) will be evaluated on a profile photograph. * Imaging evaluation: MRI examinations will be anonymized and sent to a single core laboratory for reading. One reader, a board-certified neuroradiologist with 5 years of experience in inner ear imaging, blinded to all data, will review all MRI examinations on a dedicated workstation with the Carestream Vue PACS software (Carestream Health, Rochester, NY). The main outcome measures will be the size of artifacts and the interpretability of sequences. The following MRI sequences will be performed on a 1.5T scanner (1.5T Philips®, Ingenia), covering the temporal bones : ROUTINE SEQUENCES * 2D Diffusion weighted-imaging (WI) * High-resolution 3D T2-WI TSE (DRIVE) * Post-contrast 2D T1-WI TSE (axial and coronal planes) ADDITIONAL SEQUENCES (approximately 20 minutes of additional acquisition time) : * 2D DWI (axial and coronal) phase inverted * 2D T2-WI TSE (axial and coronal planes) * High-resolution 3D T2-WI gradient echo (bFFE) * post contrast 3D T1-WI TSE and gradient echo (THRIVE)
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Artifact size, measured in millimeters, on MRI sequences.
Time Frame: baseline
mm